Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OABI | WVE |
|---|---|---|
| Price | $4.56 | $3.54 |
| Change today | ▲ 4.83% | ▲ 0.57% |
| Market cap | $662.98M | $697.55M |
| Return, 3 months | +103.6% | -43.9% |
| Return, year to date | +146.5% | -79.2% |
| Return, 1 year | +160.6% | -51.8% |
| P/E (TTM) | -12.7 | -3.3 |
| P/B | 2.5 | 1.5 |
| P/E percentile vs own 5y | 27th | 64th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +244.2% | -73.9% |
| Net profit growth (YoY) | +63.1% | -37.4% |
| Gross margin | 98.3% | – |
| Operating margin | -118.0% | -333.4% |
| Net margin | -115.1% | -309.7% |
| Return on equity | -17.0% | -68.3% |
| Analyst target vs. price | +82.7% | +416.1% |
| Analyst buy share | 100% | 92% |
| RSI (14) | 52 | 27 |
| 30-day volatility | 81.5% | 44.9% |
| Max drawdown, 1 year | -37.0% | -83.5% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
